TMP/SMX vs placebo, no treatment or non‐PCP drug
PCP‐related mortality Clinical only · patients with Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
TMP/SMX may leads to lower PCP‐related mortality Clinical only compared with placebo, no treatment or non‐PCP drug (low certainty).
1 finding from 1 review
- Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients 2014 · Cochrane Headline outcomes onlyRR 0.17 [0.03, 0.94]9 studies · 886 participantsLow